Alerts will be sent to your verified email
Verify Email
VEERHEALTH
|
Veerhealth Care
|
JFL Life Sciences
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.58 % | 12.26 % | 3.78 % |
|
5yr average Equity Multiplier
|
1.35 | 2.68 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.93 | 0.77 |
|
5yr Avg Net Profit Margin
|
3.95 % | 5.75 % | -2.26 % |
|
Price to Book
|
1.63 | 0.92 | 0.66 |
|
P/E
|
81.04 | 10.98 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
43.62 Days | 138.58 Days | 70.26 Days |
|
Inventory Days
|
56.8 Days | 96.42 Days | 107.37 Days |
|
Days Receivable
|
78.02 Days | 135.23 Days | 274.82 Days |
|
Days Payable
|
63.05 Days | 103.44 Days | 235.98 Days |
|
5yr Average Interest Coverage Ratio
|
208.02 | 4.03 | 1.81 |
|
5yr Avg ROCE
|
3.74 % | 17.72 % | 15.08 % |
|
5yr Avg Operating Profit Margin
|
0.37 % | 10.31 % | 7.68 % |
|
5 yr average Debt to Equity
|
0.07 | 0.9 | 0.97 |
|
5yr CAGR Net Profit
|
0.52 % | 50.43 % | n/a |
|
5yr Average Return on Assets
|
2.06 % | 5.01 % | 1.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.5 % | 67.47 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
-12.86 % | 0.0 | -0.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Veerhealth Care
|
JFL Life Sciences
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|